Mimedx (MDXG) EPS (Basic) (2011 - 2026)
Mimedx (MDXG) reported EPS (Basic) of -$0.07 for Q1 2026, down 244.56% sequentially from $0.05 in Q4 2024.
Mimedx (MDXG) EPS (Basic) (2011 - 2026) Analysis & Trends
Mimedx (MDXG) has 15 years of EPS (Basic) data on file, last reported at -$0.07 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) changed N/A year-over-year to -$0.07; the trailing twelve-month figure through Mar 2026 stood at -$0.07 (down 132.71% YoY), and the FY2025 full-year result was $0.33, up 15.03% from the prior year.
- EPS (Basic) retreated to -$0.07 in Q1 2026, from $0.05 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.38 in Q4 2023 to a low of -$0.11 in Q2 2022.
- A 4-year average of $0.04 and a median of $0.05 in 2024 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 668.66% in 2022, while the deepest fall reached 272.68% in 2022.
- Tracing MDXG's EPS (Basic) over 4 years: stood at $0.07 in 2022, then jumped by 434.16% to $0.38 in 2023, then slumped by 86.85% to $0.05 in 2024, then plunged by 244.56% to -$0.07 in 2026.
- Business Quant data shows MDXG's EPS (Basic) at -$0.07 in Q1 2026, $0.05 in Q4 2024, and $0.05 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.07 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.38 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | -0.09 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.11 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | -0.04 |
| Jun 30, 2021 | -0.03 |
| Mar 31, 2021 | -0.09 |
| Dec 31, 2020 | -0.17 |
| Sep 30, 2020 | -0.48 |
| Jun 30, 2020 | -0.08 |